Skip to main navigation
Skip to search
Skip to main content
Tel Aviv University Home
Update Request & User Guide (TAU staff only)
Home
Experts
Research units
Research output
Prizes
Activities
Press/Media
Student theses
Search by expertise, name or affiliation
Encephalopathy Associated with Sulindac
M. Y. Neufeld
,
A. D. Korczyn
*
*
Corresponding author for this work
Clinical Departments
Physiology Pharmacology
Research output
:
Contribution to journal
›
Article
›
peer-review
9
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Encephalopathy Associated with Sulindac'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Encephalopathy
100%
Sulindac
100%
Non-steroidal Anti-inflammatory Drugs (NSAIDs)
33%
Indomethacin
33%
Therapeutic Efficiency
33%
Indanone Derivatives
33%
Pharmacology, Toxicology and Pharmaceutical Science
Brain Disease
100%
Sulindac
100%
Non-Steroidal Anti-Inflammatory Drug
25%
Indometacin
25%
Indene Derivative
25%
Medicine and Dentistry
Brain Disease
100%
Sulindac
100%
Nonsteroid Antiinflammatory Agent
25%
Indometacin
25%
Indene Derivative
25%